MILPITAS, Calif., March 9, 2017 /PRNewswire/ -- Protagonist
Therapeutics, Inc. (NASDAQ: PTGX) today announced that Dinesh V. Patel, Ph.D., the company's President
and Chief Executive Officer, will provide a corporate overview at
the Oppenheimer & Co. 27th Annual Healthcare
Conference on Tuesday, March 21 at
2:10 pm E.T. The conference is
being held at the Westin New York Grand Central hotel in
New York, NY.
A live and archived audio webcast of the presentation can be
accessed by visiting the Investors page of Protagonist Therapeutics
corporate website at http://investors.protagonist-inc.com.
About Protagonist Therapeutics, Inc.
Protagonist
Therapeutics is a clinical-stage biopharmaceutical company with a
proprietary technology platform focused on discovering and
developing peptide-based new chemical entities to address
significant unmet medical needs. Its primary focus is on developing
first-in-class oral peptide drugs that specifically target the same
biological pathways for which there are marketed injectable
antibody drugs. Compared to injectable antibody drugs,
Protagonist's oral peptides offer preferential drug exposure in the
gastrointestinal tissue compartment, the potential for improved
safety due to minimal exposure in the blood, improved convenience
and compliance, and potentially an opportunity for the earlier
introduction of targeted therapy for inflammatory bowel disease
(IBD). Protagonist's oral peptide product candidates, PTG-100 and
PTG-200, are based on this approach with the potential to transform
the existing treatment paradigm for IBD, which includes both
ulcerative colitis and Crohn's disease. The company is also
developing an injectable hepcidin mimetic, PTG-300, for the
treatment of iron overload disorders such as beta-thalassemia, an
indication which may qualify it for orphan drug designation.
Protagonist is headquartered in Milpitas, California with its pre-clinical and
clinical development staff in California, and discovery operations both in
California and in Brisbane, Queensland, Australia. For further
information, please visit http://www.protagonist-inc.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/protagonist-therapeutics-to-present-at-the-oppenheimer--co-healthcare-conference-300420906.html
SOURCE Protagonist Therapeutics, Inc.